You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 6, June 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Folic Acid Deficiency in Hereditary Spherocytosis

Failure of Response to Massive Parenteral Doses of Cyanocobalamin

ZACHARIAS D. KOMNINOS, MD; WILLIAM F. MINOGUE, MD; JOAN SARVAJIC-DOTTOR, MD

Arch Intern Med. 1965;115(6):663-666.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN A CASE of hereditary spherocytosis, complicated by severe megaloblastic anemia, the patient failed to respond to massive doses of cyanocobalamin (vitamin B12) given parenterally but did respond rapidly to minute oral doses of folic acid. These last observations cast some doubt upon the ability of cyanocobalamin to affect megaloblastic anemias due to folic acid deficiency.

Report of a Case

A 45-year-old Irish housewife was admitted to the psychiatric division of St. Vincent's Hospital on June 26, 1963, complaining of weakness, fatigue, anorexia, pain in the tongue, palpitations, dyspnea, and ankle edema, all of about three weeks' duration.

She was first seen in this hospital in March 1959, when the diagnosis of hereditary spherocytosis was made on the basis of splenomegaly, reticulocytosis (6.8%), spherocytosis of the red blood cells, normoblastic hyperplasia of the bone marrow, and increased hypotonic fragility (Fig 1). At that time the patient was not significantly . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Department of Medicine and the Hematology Service, St. Vincent's Hospital and Medical Center of the City of New York. Clinical Assistant in Medicine (Dr. Minogue); Former Senior Resident in Hematology (Dr. Sarvajic-Dottor). Director of Hematology, St. Vincent's Hospital, and Assistant Professor of Medicine, New York University School of Medicine (Dr. Komninos).


Footnotes

Received for publication Dec 15, 1964; accepted Jan 5, 1965.

Reprint requests to St. Vincent's Hospital, New York 10011 (Dr. Komninos).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.